CIPF predoctoral researcher in advanced-therapy polymer materials for MORPHEUS

CIPF predoctoral researcher in advanced-therapy polymer materials for MORPHEUS

This is worth a targeted application from a chemistry, materials or related Master’s graduate with practical polymer laboratory experience and an interest in biomedical collaboration. The strongest signals are the ERC-funded programme, a relevant established research group and recent primary materials papers. The formal call specifies four years and €22,116.69 annual gross pay; the degree-awarding university and formal supervisory appointment remain unconfirmed. Those are material acceptance questions, not details that can be inferred from the grant’s prestige. The employer is the Príncipe Felipe Research Center (CIPF), Valencia. The saved official call is R1.04/2026, application 189, dated 27 October 2026, with a deadline of 19 November 2026 at 12:00 CET, equivalent to 19:00 Beijing time. The saved materials do not establish whether the portal is currently accepting applications. The employer’s project description gives a planned 1 January 2027 start and temporary full-time employment of 37.5 hours weekly. Confirm actual onboarding and the individual contract before making relocation commitments. Call.

The research work and its scientific value

The advertised work concerns the design, synthesis, functionalisation, purification and characterisation of complex polymeric materials for advanced-therapy research, together with analysis and interpretation of results. It is a laboratory materials position, not the separately advertised computational multi-omics position. The applicant needs evidence of working with the relevant instrumentation, understanding polymer-therapy and nanomedicine concepts, and learning new experimental skills within a multidisciplinary team. A useful scientific question is how well a material’s measured identity and behaviour support the proposed biological interpretation. Producing a candidate material is only one part of the research. The doctoral researcher must be able to explain what the characterisation actually establishes, where uncertainty or batch differences remain, and how results support or challenge a claim. The detailed work package, material systems and division between chemistry and biological assessment are not specified publicly. Do not assume every application or platform appearing in a lab paper will become this student’s thesis. MORPHEUS investigates relationships between tumour physical characteristics, metabolism and advanced nanomedicine. Its public funding description sets ambitious translational aims; these are proposed research goals rather than proven patient benefit. Success in a laboratory model does not establish clinical safety, efficacy or a usable treatment-selection tool. The value for a doctoral student is the opportunity to connect materials evidence with biological questions while learning to state the limits of that connection. European Commission project. Applicants should prepare one or two clear examples of their own work: the question, their responsibility, the characterisation evidence, uncertainty and what changed after an unexpected result. A well-explained judgement is stronger than a list of instrument names. The interview should also establish which skills can be learned after entry, what results constitute a feasible thesis and how progress will be assessed if the most ambitious application does not work.

Host, degree and training

CIPF is the research employer and host, rather than a confirmed university awarder for this vacancy. The official ERC Advanced Grant 2025 results name María Jesús Vicent, CIPF and MORPHEUS in panel PE11. This provides an independent competitive-funding signal. It is not a university ranking, a student-placement measure or a guarantee of individual supervision. No university rank should be assigned until the actual degree institution is confirmed. ERC results. The centre’s development programme describes individual learning-needs assessment, research-governance and communication training, participation expectations of five sessions in year one and three in each of years two and three, and a written annual progress report. Ask which current requirements apply to the incoming contract. Centre training complements a doctorate; it does not itself establish degree admission or completion rules. CIPF researcher development. Universitat de València’s Biomedicine and Biotechnology doctorate lists CIPF as a research environment. This supports a possible local route to discuss, not a confirmed programme or university for this student. Its monitoring information describes research and training plans, activities records and positive annual evaluation, with reassessment within six months after a negative decision. Apply these rules only if that programme is selected. The employment start, university registration and permit dates need an explicit arrangement. Programme context, doctoral monitoring.

PI, facilities and recent papers

Vicent leads MORPHEUS and CIPF’s Polymer Therapeutics Laboratory. The lab documents an established multidisciplinary group, and her December 2025 CV records doctoral supervision and academic/industrial links. These are useful indications of a research and training environment. They do not confirm her formal appointment as this student’s thesis director or identify the day-to-day materials mentor. Ask how supervision, specialist training and access to collaborators will be divided. Lab, dated CV. The current NMR facility describes structural and purity analysis for compounds and polymers, with 300, 500 and 600 MHz instruments, PI-requested access and required introductory training. The advanced microscopy facility provides imaging, quantitative-analysis support and user training. These are relevant shared capabilities; they do not establish individual instrument time, consumables funding or that every advertised method is mandatory. NMR, microscopy. Three recent team papers show why materials and biological evidence need to be considered together:

1. Pegoraro et al., Advanced Materials 37(8), e2411595 (2025) studies polymer carriers and subcellular distribution. For this application, the relevance is the link between material behaviour and biological readouts. Vicent is a corresponding author; the published contribution record attributes conceptualisation, funding and project administration to her with support from Conejos-Sanchez. The paper discloses a patent and industrial coauthors. These are research and translation links, not proof of clinical effectiveness or a promised industry placement. Primary abstract and disclosures.
2. Pegoraro, Guinart et al., Journal of Materials Chemistry B 13(8), 2658–2665 (2025), DOI 10.1039/D4TB02434F, connects a physical change in a material with cellular readouts. Pegoraro and Guinart are co-first authors; Conejos-Sánchez, Feringa and Vicent are corresponding authors. It illustrates collaborative chemistry and the need to assess function alongside material properties, but remains preclinical. The abstract does not assign each author’s experimental contribution or establish this platform as the incoming thesis topic. Primary paper.
3. Boix-Montesinos et al., Journal of Controlled Release 381, 113584 (2025) addresses functional biomarkers and advanced preclinical breast-cancer models. It matters downstream of material characterisation: model choice and heterogeneity affect what a biological result can mean. The publisher’s indexed record credits Vicent with supervision, validation and resources among other work. It is not a prospectively validated clinical patient-selection tool. Primary publication. The reading scope is the first paper’s complete primary indexed abstract/disclosure and selected contribution statement, the RSC paper’s complete abstract/authorship/date, and the third paper’s publisher-indexed highlights, abstract opening and selected contribution record. Full methods, raw datasets and clinical validation were not audited. A polymer-degradation manuscript described as under revision in the dated CV was not counted as a published paper.

Funding and Valencia costs

The European Commission records MORPHEUS grant 101268299 with €2,499,745 EU contribution, from September 2026 to August 2031. This is the whole project’s budget, not a personal stipend or a guarantee of a five-year employment contract. The formal conditions for this exact R1.04/2026 vacancy specify four years, €22,116.69 annual gross pay, a January 2027 start and 37.5 hours per week. The salary follows the stated Valencia private-health-sector collective-agreement level; it is not take-home income. Formal conditions, p.6. Grant facts. Confirm pay instalments, contractual updates, probation and the precise onboarding date. Also ask which doctoral fees, research visits and completion costs are covered. Dividing the annual gross salary by 12 gives about €1,843.06 as a comparison only, not a promised monthly payslip. Net pay and fee coverage remain unknown, so the partial cost reference below cannot establish a reliable surplus. For a local reference, UV’s incoming-student guide quotes a shared room at €350–450 per month excluding bills, utilities around €50 per person and groceries/small expenses around €250. The sum of €650–750 is partial student context, excluding internet, transport, deposits, fees, immigration and travel. It is not a 2027 rental quote, an employed doctoral researcher’s complete budget or guaranteed housing. Request real quotations and retain arrival reserves. Valencia cost reference.

Eligibility and application

The employer seeks a Master’s in chemistry, pharmacy, biotechnology, biomedical sciences, materials science or a related discipline, high spoken/written English, advanced nanomedicine/polymer-therapy knowledge and practical experience with polymer synthesis and characterisation instrumentation. Independent work, teamwork and motivation to develop new skills matter. No IELTS or GPA threshold or nationality restriction was established in the available role description; absence of a listed restriction does not guarantee admission or employment eligibility. The saved English page extract also lists “Economics” under Requirements, which conflicts with its narrative degree fields; ask whether that taxonomy affects the formal MSc criterion. Use the official employment portal, application 189 / reference R1.04/2026. The saved call page explicitly requires the CV to omit name, gender, age, marital status, nationality and photograph. Ask how portal identity details are separated from the anonymous CV. The formal PDF requests CV, cover letter and references through the employment portal, with the reference number in the subject field. Its anonymity list omits the word “name”, while the saved web page includes it; follow the stricter web instruction and ask HR how identity is handled. The formal HR contact is recursoshumanos@cipf.es; the collected project description also lists arodrigo@cipf.es. Email enquiries should not be treated as a replacement for portal submission. Official application page. The published assessment allocates 15% to training (Master’s 5%, English 10%), 20% each to organic synthesis for polymer chemistry, physicochemical characterisation and in-vitro cell-model experience, 5% to specified other considerations (disability certification of at least 33% or being a victim of gender-based violence), and 20% to interview. After essential-eligibility screening and merit assessment, the three highest-scoring candidates proceed to interview. Prepare evidence for the relevant categories; do not describe the cell-model merit as a separate mandatory degree. Confirm reference format and interview timing. Formal selection and application, pp. 6–7. Chinese applicants need both employment credential review and the eventual university’s admission decision. If registered at UV, its general doctoral rules require official degrees/transcripts, appropriate translations and legalisation, equivalence review and ten-point grade conversion. For a non-EHEA Master’s, evidence of doctoral access in the issuing country is required; China appears in its Hague Apostille list. These are conditional UV rules, not a verified admission outcome or an instruction to assume UV is the awarder. Language documentation is still to be confirmed. Admission documents, foreign qualification rules. For a China-based applicant, HR should also confirm the research residence/work route, sponsor responsibilities and realistic timetable. Spain’s current ministry guidance includes eligible third-country researchers and doctoral candidates, subject to contract/hosting and other requirements. It does not guarantee an individual permit or settle the correct route for this offer. Research authorisation.

Decision, career value and questions

Transferable value lies in polymer characterisation, evidence-based material-quality assessment, reproducible reporting and communication between chemistry and biomedical teams. These can support biomaterials research, analytical work or industrial R&D. The PI’s industrial links and CIPF’s selected alumni stories demonstrate possible routes, but do not provide a representative employment rate or guarantee a postdoctoral or industry role. Alumni examples. Before submitting, confirm the anonymous-CV process and reference format for this exact reference. Before accepting, obtain the signed contract, net-pay estimate and fees/visits arrangements, degree university/programme, formal and daily supervisors, Chinese-qualification and English assessment, permit/registration/start alignment, instrument access, research milestones, publication/IP arrangements and funding through completion. The saved recruitment materials specify the submission period, but current acceptance status has not been confirmed. The programme is scientifically attractive for a suitable experimental applicant, while the remaining personal conditions require direct clarification.

Evidence and Sources

The linked sources support their associated claims. Individual contractual and doctoral conditions remain subject to the named vacancy and formal admission.